Google Scholar | Citations: 16429| h-index: 32 | i10-index: 482
Clinical pharmacy: analysis of pharmaceutical interventions during the implementation of the service in a pediatric hospital
PDF (Portuguese (Brazil))

Keywords

Clinical pharmacy service
Pediatrics
Patient safety

How to Cite

Clinical pharmacy: analysis of pharmaceutical interventions during the implementation of the service in a pediatric hospital. (2026). Electronic Journal Collection Health, 26(7), e23430. https://doi.org/10.25248/reas.e23430.2026

Copyright © | All rights reserved.

The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.

Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.

Total reproduction
It is expressly prohibited and must be authorized by the journal.

Abstract

Objective: To analyze pharmaceutical interventions during the implementation of the clinical pharmacy service in the pediatric infectious and parasitic diseases ward of the University Maternal and Child Hospital in São Luís, Maranhão. Methods: This cross-sectional, observational, and retrospective study was conducted based on an analysis of pharmaceutical interventions during the first five months of service implementation. Data were obtained through consultation of the Clinical Pharmacy sector's database. Medication-related problems were classified according to the Pharmacotherapy Workup methodology, and interventions were categorized and evaluated for accessibility. The study was approved by the Ethics Committee under number 91952825.4.0000.5086. Results: A total of 203 medication-related problems were identified, predominantly in the safety category (65.52%), followed by effectiveness (25.12%), indication (8.37%), and adherence (0.99%). The most frequent pharmaceutical interventions were monitoring drug interactions (36.94%), adjusting infusion time and/or rate (16.75%), and dose adjustment (16.26%). Regarding acceptability, 87.68% of the interventions were accepted. Conclusion: The results show a high incidence of medication-related problems in pediatric patients. Pharmaceutical interventions showed high acceptability, highlighting the pharmacist's contribution to multidisciplinary care.

PDF (Portuguese (Brazil))

References

ARAUJO EO, et al. Intervenções farmacêuticas em uma Unidade de Terapia Intensiva de um Hospital Universitário. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 2017; 8(3): 25-30.

AMEER A, et al. Systematic literature review of hospital medication administration errors in children. Integrated Pharmacy Research and Practice, 2015; 4: 153-165.

BECKER GC, et al. Perfil de utilização de medicamentos em pacientes pediátricos em cuidados intensivos. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 2016; 7(2): 42-47.

BEKELE F, et al. Drug-related problems among patients with infectious disease admitted to medical wards of Wollega University Referral Hospital: Prospective observational study. SAGE Open Medicine, 2021; 9: 2050312121989625.

BEZERRIL NKAC, et al. Intervenção farmacêutica na detecção e resolução de problemas relacionados a medicamentos em pacientes pediátricos hospitalizados: uma revisão narrativa. Revista Ibero-Americana De Humanidades, Ciências E Educação, 2025; 1(3): 198–207.

BRAGA GWA, et al. Uso racional de antibióticos na infância: desafios na prática pediátrica. Revista Científica Multidisciplinar O Saber, 2026; 1(1).

BRITO AM, et al. Análise de intervenções farmacêuticas utilizando um instrumento de acompanhamento farmacêutico em uma Unidade de Terapia Intensiva Pediátrica. Clinical and Biomedical Research, 2022; 42(2): 112-120.

CIPOLLE RJ, et al. Pharmaceutical care practice: the patient-centered approach to medication management. New York: McGraw-Hill Medical, 2012. p697.

CONSELHO FEDERAL DE FARMÁCIA. Resolução da Diretoria Colegiada – Resolução nº 585, de 29 de agosto de 2013. Regulamenta as atribuições clínicas do farmacêutico e dá outras providências. Diário Oficial da União, Brasília-DF, 30 ago. 2013. Disponível em: https://www.cff.org.br/userfiles/file/resolucoes/585.pdf. Acesso em: 20 de jan. 2025.

DAMASCENO MPR, et al. Reação à infusão de vancomicina: relato de caso. Revista de Medicina (São Paulo), 2023; 102(1): e-199049.

DIAS D, et al. Evaluation of pharmaceutical clinical interventions in the ICU of a public hospital of Santa Catarina. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde. 2018; 9(3): e093.005

DINIZ JA, et al. Intervenção clínica do cuidado farmacêutico como indicador de qualidade da assistência hospitalar em pediatria. Residência Pediátrica, 2024; 14(1):1-7.

FREIRE EC, et al. Frequency and classification of drug-related incidents in an infectious disease ward of a high-complexity hospital. Future Journal of Pharmaceutical Sciences, 2025; 11: 158.

MAGALHÃES ACAF, et al. Avaliação da implantação do serviço de farmácia clínica na Unidade de Terapia Intensiva para contribuir na segurança do paciente. Revista Médica de Minas Gerais, 2016; 26(Supl 5): S16-S22.

MAGEDANZ L. Implantação do serviço de farmácia clínica em hospitais públicos do Distrito Federal, Brasil. Dissertação (Mestrado em Ciências e Tecnologias em Saúde) – Universidade de Brasília, Brasília, 2020, p135.

MEDEIROS IAS, OLIVEIRA FS. Farmacoterapia pediátrica: as particularidades da utilização de fármacos em pediatria. Revista Saúde & Ciência Online. 2020;9 (3): 117–133.

MECHESSA DF, et al. Drug-related problem and its predictors among pediatric patients with infectious diseases admitted to Jimma University Medical Center, Southwest Ethiopia: Prospective observational study. SAGE Open Medicine. 2020; 8:2050312120970734.

MOGES TA, et al. Clinical pharmacists' interventions about drug therapy problems and its acceptability by prescribers among pediatric hospitalized patients with infectious diseases in resource-limited settings. BMC Infect Diseases, 2025; 25(1):629.

OKUMURA L, et al. Relation between safe use of medicines and clinical pharmacy services at pediatric intensive care units. Revista Paulista de Pediatria, 2016; 34(4):397-402.

PROT-LABARTHE S, et al. Pediatric drug-related problems: a multicenter study in four French-speaking countries. International Journal of Clinical Pharmacy, 2013; 35: 251-259.

RESENDE NH, et al. Problemas relacionados ao uso de medicamentos em pacientes com tuberculose e HIV/AIDS em hospital referência. Einstein (São Paulo). 2019;17(4): eAO4696.

SHAREEF J, et al. Assessment of potential drug-drug interactions in hospitalized patients with infectious diseases: an experience from a secondary care hospital. F1000Research. 2025; 13:164.

SHIRZAD-YAZDI N, et al. Drug-related problems among pediatric intensive care units: prevalence, risk factors, and clinical pharmacists' interventions. BMC Pediatrics, 2024; 24(1): 714.

SOCIEDADE BRASILEIRA DE PEDIATRIA. Manejo da Febre Aguda: documento científico. Departamentos Científicos de Pediatria Ambulatorial e de Infectologia (2019–2021), 05 out. 2021. Disponível em: https://www.sbp.com.br/fileadmin/user_upload/23229c-DC_Manejo_da_febre_aguda.pdf. Acesso em: 2 fev. 2026.

SPEZIA IA, CIMAROSTI HI. Identification of drugs-related problems and pharmacists’ interventions in a hospital in Southern Brazil. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 2022; 13(2): 0794.

ÜNDER D, et al. Clinical Pharmacist-Led Medication Review in Hospitalized Confirmed or Probable Patients with COVID-19 During the First Wave of COVID-19 Pandemic. Turkish Journal of Pharmaceutical Sciences, 2024; 21(2): 152-158.